BIIB Headlines | Biogen Idec Inc. Stock - Yahoo! UK & Ireland Finance

Sat 25 May 2013 23:53 - Deutsche Märkte geschlossen

0.63%

More On BIIB

Quotes

Derivatives

Warrants
Investment Products

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Biogen Idec Inc. (BIIB)

-NasdaqGS

235.24 2.62(1.13%) 24 May 21:00|After Hours: : 234.67 0.57 (0.24%) 24 May 21:42

Add to Portfolio

Headlines

Get Headlines for:

Thursday, 23 May 2013

Elan rejects Royalty's $6.4 bln raised offerReuters - UK Focus (Thu 23 May)

Monday, 20 May 2013

Royalty raises Elan bid, issues ultimatum to shareholdersReuters - UK Focus (Mon 20 May)
Royalty ups Elan bid and issues shareholder ultimatumReuters (Mon 20 May)
XenoPort to drop multiple sclerosis drug, shares fallReuters - UK Focus (Mon 20 May)
Royalty Pharma ups offer for Elan to $12.50/shrReuters - UK Focus (Mon 20 May)
Elan strikes more deals to repel Royalty bidReuters (Mon 20 May)
Elan strikes more deals, agrees second share buybackReuters - UK Focus (Mon 20 May)

Wednesday, 15 May 2013

Elan says Royalty wanted to take it private before Tysabri dealReuters - UK Focus (Wed 15 May)

Monday, 13 May 2013

Elan's $1 billiondrug royalty deal aids bid defenceReuters (Mon 13 May)
Elan's $1 bln drug royalty deal aids bid defenceReuters - UK Focus (Mon 13 May)
Elan strikes $1 bln royalty deal with TheravanceReuters - UK Focus (Mon 13 May)

Wednesday, 8 May 2013

REUTERS SUMMIT-Faster drug approvals a tonic for pharma industryReuters - UK Focus (Wed 8 May)

Thursday, 2 May 2013

UPDATE 1-Elan considered buying Royalty before becoming its targetReuters - UK Focus (Thu 2 May)
Royalty Pharma stands by reduced Elan bidReuters - UK Focus (Thu 2 May)

Thursday, 25 April 2013

UPDATE 3-Biogen profit beats estimates, raises 2013 forecastReuters - UK Focus (Thu 25 Apr)

Wednesday, 24 April 2013

UPDATE 2-Elan tees up deals as sales of prized drug rise sharplyReuters - UK Focus (Wed 24 Apr)

Monday, 22 April 2013

Elan rejects Royalty bid as grossly undervaluing its prospectsReuters (Mon 22 Apr)
UPDATE 2-Elan rejects Royalty bid as grossly undervaluing its prospectsReuters - UK Focus (Mon 22 Apr)

Thursday, 18 April 2013

J&J stake sale clouds Royalty bid for ElanReuters (Thu 18 Apr)
UPDATE 3-J&J stake sale clouds Royalty bid for ElanReuters - UK Focus (Thu 18 Apr)

Older Headlines

Copyright © 2009 Yahoo! All rights reserved.

Quotes are real-time for NASDAQ, NYSE, and NYSE MKT. See also delay times for other exchanges. All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein. Real-Time continuous streaming quotes are available through our premium service. You may turn streaming quotes on or off.

Fundamental company data provided by Capital IQ. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). International historical chart data, daily updates, fund summary, fund performance, dividend data and Morningstar Index data provided by Morningstar, Inc.